# Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage

> **NCT03523234** · NA · UNKNOWN · sponsor: **Peng Zhang** · enrollment: 300 (estimated)

## Conditions studied

- Small-cell Lung Cancer

## Interventions

- **DRUG:** neoadjuvant chemotherapy
- **PROCEDURE:** radical surgery for stage II and IIIA small cell lung cancer (SCLC)
- **PROCEDURE:** prophylactic cranial irradiation
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT03523234
- **Lead sponsor:** Peng Zhang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10
- **Primary completion:** 2023-07
- **Final completion:** 2023-07
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2018-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03523234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03523234, "Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03523234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*